Medical Devices

The biggest trends in CVD management currently revolve around remote patient monitoring (RPM), which enables the patients' health to be examined from a distance.

Although the COVID-19 pandemic has interrupted the 3D printing sector and its end users (such as printing bureaus), new directions of travel have nonetheless emerged. Some opportunities have even been directly prompted by the pandemic.

Given the considerable impact that CVD has on many people's lives, it is no surprise that the demand for solutions is exploding. IDTechEx Research found that the market for cardiovascular disease technology will exceed $40 billion by the year 2030.

Telehealth has been poised to disrupt healthcare for many years, but unfortunately has faced a slow rise in adoption. This has changed in the COVID-19 crisis.

In its recently published report "Innovations in Robotic Surgery 2020-2030", IDTechEx forecasts that the robotic surgery market will reach over $12 billion by 2030. The report breaks down the market landscape and emerging technologies in the field of robotic surgery.

IDTechEx identifies top future technologies in healthcare. With demographic changes such as the aging of the population, they forecast there to be strong growth in technologies that help healthcare providers manage the growing burden on the healthcare system while maintaining high quality care.

Healthcare Sensor Innovations 2020, hosted in San Jose on March 17-18, identifies and assesses the opportunities for printed and flexible electronics in healthcare as the technology enables a new wave of medical wearable devices.

Healthcare Sensor Innovations North America debut on Marc, 17-18, 2020 in San Jose, USA will focus on the latest developments in the use of wearables and sensors in point of care diagnostics and continuous monitoring.

Attendees at Healthcare Sensor Innovations USA 2020 will hear from industry representatives on how the next wave of connected and wearable medical devices will bring increased benefits to patients, healthcare providers, insurers, and the pharmaceutical industry.

Cardiovascular disease (CVD) must be better managed for patient care to improve. The protocols for monitoring patients are rapidly evolving. Historically, patients who fall ill are required to travel in order to visit a general practitioner or hospital. This procedure may soon become a thing of the past.